{"id":"https://openalex.org/W4405750428","doi":"https://doi.org/10.18203/2319-2003.ijbcp20243846","title":"An overview of biosimilars","display_name":"An overview of biosimilars","publication_year":2024,"publication_date":"2024-12-24","ids":{"openalex":"https://openalex.org/W4405750428","doi":"https://doi.org/10.18203/2319-2003.ijbcp20243846"},"language":"en","primary_location":{"id":"doi:10.18203/2319-2003.ijbcp20243846","doi":"https://doi.org/10.18203/2319-2003.ijbcp20243846","is_oa":true,"landing_page_url":"https://doi.org/10.18203/2319-2003.ijbcp20243846","pdf_url":null,"source":{"id":"https://openalex.org/S2764844374","display_name":"International Journal of Basic & Clinical Pharmacology","issn_l":"2279-0780","issn":["2279-0780","2319-2003"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4322697004","host_organization_name":"Medip Academy","host_organization_lineage":["https://openalex.org/P4322697004"],"host_organization_lineage_names":["Medip Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Basic &amp; Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.18203/2319-2003.ijbcp20243846","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5119740633","display_name":"Shanmugarajan Dayanidhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141935","display_name":"ESIC Hospital","ror":"https://ror.org/04were380","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210141935"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Dayanidhi Shanmugarajan","raw_affiliation_strings":["Department of Pharmacology, ESIC Medical college and Hospital, KK Nagar, Chennai, Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, ESIC Medical college and Hospital, KK Nagar, Chennai, Tamil Nadu, India","institution_ids":["https://openalex.org/I4210141935"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5119740633"],"corresponding_institution_ids":["https://openalex.org/I4210141935"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.21133811,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"1","first_page":"117","last_page":"123"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":1.0},{"id":"https://openalex.org/keywords/biological-drugs","display_name":"biological drugs","score":0.9739999771118164},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.6259999871253967},{"id":"https://openalex.org/keywords/biosimilar-development","display_name":"biosimilar development","score":0.6119999885559082},{"id":"https://openalex.org/keywords/biosimilar-approval","display_name":"biosimilar approval","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.6460000276565552},{"id":"https://openalex.org/keywords/clinical-effectiveness","display_name":"clinical effectiveness","score":0.5789999961853027},{"id":"https://openalex.org/keywords/pharmaceutical-market","display_name":"pharmaceutical market","score":0.5080000162124634},{"id":"https://openalex.org/keywords/patent-expiration","display_name":"patent expiry","score":0.41499999165534973}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9720118045806885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27874621748924255},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09141352772712708}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.18203/2319-2003.ijbcp20243846","doi":"https://doi.org/10.18203/2319-2003.ijbcp20243846","is_oa":true,"landing_page_url":"https://doi.org/10.18203/2319-2003.ijbcp20243846","pdf_url":null,"source":{"id":"https://openalex.org/S2764844374","display_name":"International Journal of Basic & Clinical Pharmacology","issn_l":"2279-0780","issn":["2279-0780","2319-2003"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4322697004","host_organization_name":"Medip Academy","host_organization_lineage":["https://openalex.org/P4322697004"],"host_organization_lineage_names":["Medip Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Basic &amp; Clinical Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.18203/2319-2003.ijbcp20243846","doi":"https://doi.org/10.18203/2319-2003.ijbcp20243846","is_oa":true,"landing_page_url":"https://doi.org/10.18203/2319-2003.ijbcp20243846","pdf_url":null,"source":{"id":"https://openalex.org/S2764844374","display_name":"International Journal of Basic & Clinical Pharmacology","issn_l":"2279-0780","issn":["2279-0780","2319-2003"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4322697004","host_organization_name":"Medip Academy","host_organization_lineage":["https://openalex.org/P4322697004"],"host_organization_lineage_names":["Medip Academy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Basic &amp; Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.504800021648407}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1993762334","https://openalex.org/W2914532353","https://openalex.org/W4229777120","https://openalex.org/W2904055208","https://openalex.org/W2571592438","https://openalex.org/W4321221717","https://openalex.org/W4250572628","https://openalex.org/W4386024082","https://openalex.org/W4380149278","https://openalex.org/W2971993847"],"abstract_inverted_index":{"The":[0,124],"paradigm":[1],"of":[2,28,47,69,84,98,107,130,181],"pharmacological":[3],"therapy":[4],"in":[5,63,104,117],"diseases":[6],"is":[7,138,167],"shifting":[8],"from":[9,201],"conventional":[10,108,203],"small":[11,109],"molecule":[12,110],"drugs":[13,16,22,41,87,102,134,147,185,199],"to":[14,53,79,150,176,186],"biological":[15,86,101,161],"produced":[17],"by":[18,153,192],"living":[19],"systems.":[20],"Biological":[21,40],"have":[23,177],"extensively":[24],"ramified":[25],"into":[26],"therapies":[27],"various":[29],"conditions":[30],"such":[31],"as":[32,90],"autoimmune":[33],"disorders,":[34],"haematological":[35],"conditions,":[36],"cancers":[37],"and":[38,65,114,122,174,209],"others.":[39],"are":[42,61,88,94,148],"currently":[43],"the":[44,48,54,76,85,99,105,127,159,172,189,202],"diamond":[45],"mine":[46],"pharmaceutical":[49,59],"drug":[50],"market.":[51],"Due":[52],"enormous":[55],"market":[56],"value,":[57],"other":[58],"companies":[60],"keen":[62],"producing":[64],"marketing":[66,164],"generic":[67,82],"versions":[68,83],"these":[70],"innovator":[71],"(reference)":[72],"biologic":[73],"companies,":[74],"once":[75],"patents":[77],"start":[78],"expire.":[80],"These":[81],"called":[89],"biosimilars.":[91],"However,":[92],"biosimilars":[93,131],"not":[95],"exactly":[96],"generics":[97,133],"originator":[100],"like":[103],"case":[106],"drugs.":[111],"Various":[112],"controversies":[113],"perplexities":[115],"exist":[116],"their":[118,139,205,213],"production,":[119],"approval,":[120],"marketing,":[121],"prescription.":[123],"reason":[125],"for":[126,135,163,171],"mere":[128],"existence":[129],"or":[132],"that":[136],"matter":[137],"reduced":[140],"cost":[141],"with":[142,158,212],"preserved":[143],"clinical":[144],"effectiveness.":[145],"Biosimilar":[146],"subject":[149],"rigorous":[151],"scrutiny":[152],"a":[154,178],"thorough":[155],"comparative":[156],"evaluation":[157],"reference":[160],"product":[162],"approval.":[165],"It":[166],"also":[168],"equally":[169],"important":[170],"physicians":[173],"pharmacists":[175],"sound":[179],"body":[180],"knowledge":[182],"about":[183],"biosimilar":[184,198],"optimally":[187],"avail":[188],"benefits":[190],"offered":[191],"them.":[193],"This":[194],"review":[195],"highlights":[196],"how":[197],"differ":[200],"drugs,":[204],"development":[206],"process,":[207],"issues,":[208],"challenges":[210],"associated":[211],"use.":[214]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}
